US › Healthcare

Neuronetics Inc (STIM)

US · Healthcare · Medical Devices

$2.30+6.48%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$34.5M
Revenue YoY
+7.8%
Net profit
$-10.8M
Profit YoY
+14.9%
EPS
$-0.15
EPS estimate
$-0.17
Net margin
-31.3%

EPS came in at -0.15 against a street estimate of -0.17 — a beat of 11.8%.

Key statistics

Market cap
$137.8M
Forward P/E
0.0
P/B
10.36
Book value
$0.19
EPS (TTM)
$-0.54
52-week high
$4.85
52-week low
$0.80
50-day MA
$1.50
200-day MA
$1.67
Beta
1.06

Analyst view

Analysts rate Neuronetics Inc a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $4.50.

Shareholding

Insiders
33.05%
Institutions
59.71%

Largest institutional holders

FundStake
Madryn Asset Management, LP26.55%
UBS Group AG4.13%
Balyasny Asset Management LLC3.94%
BlackRock Inc3.33%
Vanguard Capital Management, LLC2.94%
Lane Generational LLC2.55%
FourWorld Capital Management LLC2.14%
Masters Capital Management LLC1.44%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Neuronetics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.